United States - English - NLM (National Library of Medicine)

heritage pharmaceuticals inc d/b/a avet pharmaceuticals inc - griseofulvin (unii: 32hrv3e3d5) (griseofulvin - unii:32hrv3e3d5) - griseofulvin is contraindicated in patients with porphyria or hepatocellular failure, and in individuals with a history of hypersensitivity to griseofulvin. griseofulvin may cause fetal harm when administered to a pregnant woman. two published cases of conjoined twins have been reported in patients taking griseofulvin during the first trimester of pregnancy, therefore, griseofulvin is contraindicated in women who are or may become pregnant during treatment. women taking estrogen-containing oral contraceptives may be at increased risk of becoming pregnant while on griseofulvin (see also precautions, drug interactions ) . if this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. although no direct causal relationship has been established, spontaneous abortion has been reported rarely coincident with the use of griseofulvin. note: the maximum recommend human dose (mrhd) was set at 500 mg/day for the multi

New Zealand - English - Medsafe (Medicines Safety Authority)

origen pharmaceuticals limited - griseofulvin - tablet - 125mg, 500mg - active: griseofulvin

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

mitsubishi tanabe pharma corporation - vadadustat - white tablet, diameter: about 8.1 mm, thickness: about 4.4 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

mitsubishi tanabe pharma corporation - vadadustat - yellow oval tablet, major axis: approximately 12.9 mm, minor axis: approximately 7.8 mm, thickness: approximately 6.0 mm

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hovid berhad - griseofulvin -

Philippines - English - FDA (Food And Drug Administration)

seo kyung pharm corporation; distributor: seo kyung pharm corporation - citicoline - solution for injection (iv/im) - 250mg/ml (1g / 4ml)

Philippines - English - FDA (Food And Drug Administration)

seo kyung pharm corporation; distributor: seo kyung pharm corporation - filidon - solution for injection (iv/im) - 250mg/ml (500mg / 2ml)

European Union - English - EMA (European Medicines Agency)

akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - antianemic preparations - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

United States - English - NLM (National Library of Medicine)

riconpharma llc. - griseofulvin (unii: 32hrv3e3d5) (griseofulvin - unii:32hrv3e3d5) - griseofulvin 125 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - griseofulvin - oral suspension - 250mg/1ml